• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·AKI.NS
Share

AKI India Limited Stocks

₹ 4.24Last Updated 28.07.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 4.55M

₹ 4.24
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

AKI India Limited, founded in 1994 and headquartered in Kanpur, India, is a manufacturer and seller of a broad range of leather and associated products. The company's operations are structured across distinct segments: Tannery, Footwear, Equestrian, Leather, and Chemical. Its comprehensive product portfolio encompasses diverse leather goods like upholstery, wallets, bags, and belts; various footwear types including countryside boots, boat shoes, riding shoes, and both casual and formal designs; a selection of equestrian equipment such as bridles, halters, chaps, and horse rugs; and a variety of other leather accessories and chemicals. In addition to serving the Indian market, AKI India Limited exports its products globally to regions including the United Arab Emirates, the United Kingdom, other parts of Europe, South Africa, and Australia.

Company Valuation

Fairly valued
4/7

Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.07.2026 18:25

The Largest Deal in the U.S. Accounting Industry in 25 Years: Mid-Cap CBIZ to Acquire a Competitor

30.07.2026 17:53

U.S. economic growth slowed and fell short of expectations in the second quarter. What's next?

30.07.2026 17:35

Egypt reported a drone attack on ships in a Mediterranean port

30.07.2026 17:11

The fund run by the 24-year-old “AI Nostradamus” needed new capital following the tech sector’s downturn

30.07.2026 16:50

Shares of the micro-cap biotech company Processa plummeted following the announcement of a merger. What went wrong?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026